299 related articles for article (PubMed ID: 11425937)
1. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.
Houlden H; Baker M; Morris HR; MacDonald N; Pickering-Brown S; Adamson J; Lees AJ; Rossor MN; Quinn NP; Kertesz A; Khan MN; Hardy J; Lantos PL; St George-Hyslop P; Munoz DG; Mann D; Lang AE; Bergeron C; Bigio EH; Litvan I; Bhatia KP; Dickson D; Wood NW; Hutton M
Neurology; 2001 Jun; 56(12):1702-6. PubMed ID: 11425937
[TBL] [Abstract][Full Text] [Related]
2. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
3. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
4. Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.
Valentino RR; Tamvaka N; Heckman MG; Johnson PW; Soto-Beasley AI; Walton RL; Koga S; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
Acta Neuropathol Commun; 2020 Sep; 8(1):162. PubMed ID: 32943110
[TBL] [Abstract][Full Text] [Related]
5. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
6. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
[TBL] [Abstract][Full Text] [Related]
7. 5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.
Cruchaga C; Vidal-Taboada JM; Ezquerra M; Lorenzo E; Martinez-Lage P; Blazquez M; Tolosa E; ; Pastor P
Neurobiol Dis; 2009 Feb; 33(2):164-70. PubMed ID: 19022385
[TBL] [Abstract][Full Text] [Related]
8. Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Tolosa E; Muñoz E; Martí MJ; Valldeoriola F; Molinuevo JL; Calopa M; Oliva R
Mov Disord; 2002 May; 17(3):550-6. PubMed ID: 12112206
[TBL] [Abstract][Full Text] [Related]
9. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
10. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
Dickson DW
J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
Yoshida M
Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
[TBL] [Abstract][Full Text] [Related]
12. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
[TBL] [Abstract][Full Text] [Related]
13. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.
Liu WK; Le TV; Adamson J; Baker M; Cookson N; Hardy J; Hutton M; Yen SH; Dickson DW
Ann Neurol; 2001 Oct; 50(4):494-502. PubMed ID: 11601500
[TBL] [Abstract][Full Text] [Related]
14. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Yokoyama JS; Karch CM; Fan CC; Bonham LW; Kouri N; Ross OA; Rademakers R; Kim J; Wang Y; Höglinger GU; Müller U; Ferrari R; Hardy J; ; Momeni P; Sugrue LP; Hess CP; James Barkovich A; Boxer AL; Seeley WW; Rabinovici GD; Rosen HJ; Miller BL; Schmansky NJ; Fischl B; Hyman BT; Dickson DW; Schellenberg GD; Andreassen OA; Dale AM; Desikan RS
Acta Neuropathol; 2017 May; 133(5):825-837. PubMed ID: 28271184
[TBL] [Abstract][Full Text] [Related]
15. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
[TBL] [Abstract][Full Text] [Related]
16. Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants.
Razquin C; Ortega-Cubero S; Rojo-Bustamante E; Diez-Fairen M; Lorenzo E; Alonso E; Ezquerra M; Ross OA; Carcel M; Lorenzo-Betancor O; Soto AI; Burgess JD; Ertekin-Taner N; Dickson DW; Pastor MA; Tolosa E; Pastor P
Neurobiol Aging; 2018 Jun; 66():177.e7-177.e10. PubMed ID: 29398119
[TBL] [Abstract][Full Text] [Related]
17. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
[TBL] [Abstract][Full Text] [Related]
18. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy.
Higgins JJ; Golbe LI; De Biase A; Jankovic J; Factor SA; Adler RL
Neurology; 2000 Nov; 55(9):1364-7. PubMed ID: 11087782
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
[TBL] [Abstract][Full Text] [Related]
20. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.
Gentry EG; Henderson BW; Arrant AE; Gearing M; Feng Y; Riddle NC; Herskowitz JH
J Neurosci; 2016 Jan; 36(4):1316-23. PubMed ID: 26818518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
